Replies to post #45321 on RespireRx Pharmaceuticals Inc (RSPI)

[Dj56]

Regardless of funding, it may have been the faster track to getting FDA approval if it's efficacy continues to be borne out?

[LTListener]

I agree. They look to historically struggle getting any funding for their programs. I think the point out of the NIH trials, is that if the final preclincals continue to point to human trials, then the NIH will be funding some of that via grants and I think the investment thesis is "purse strings" will open from BP to take the baton and run with it. Given the current published success with KRM-II-81 in preclinicals for a wide array of pain indications and epilepsy, the thought or maybe the "gamble" is there are various paths of development and partnerships possibly under consideration to move the ball forward. I would speculate all other drug development programs would be on hold until they have direction with this.

One has to admit the silence and lack of 10-k, and a BOD loan... considering the extremely positive progress with the NIH is a change in the status quo, ho hum OTC penny stock life. Could also be desperation. But in OTC world, there is a fine line and sudden switch possible between desperation and a 100 bagger... lol